During hyperglycaemia, ROS produced by AR can accelerate thrombus formation in diabetic vessels by activating c-Myc, inhibiting miRNA-24 and enhancing von Willebrand factor (VWF) release from endothelial cells in diabetic patients [49]. This evidence concerns the gene VWF and Hyperglycemia.